Blocking the CD47-SIRPα axis is thus an attractive approach to foster tumor cell killing by tumor-associated macrophages (TAMs) and boost cross-priming of anti-tumor T cells by dendritic cells (DC). This evidence concerns the gene CD47 and neoplasm.